Showing results (21-30 of 44) with videos related to
Sort By:
Pageof 5
Thorax|November 1, 1996
Simian virus 40 large T antigen (SV40LTAg) primer specific DNA amplification in human pleural mesothelioma tissueC Pepper, B Jasani, H Navabi, et al.Environmental Technology|February 18, 2014
Enhanced biogas production using cow manure to stabilize co-digestion of whey and primary sludgeA Shilton, N Powell, A Broughton, et al.European Journal of Heart Failure|December 27, 2005
CRT improves the exercise capacity and functional reserve of the failing heart through enhancing the cardiac flow- and pressure-generating capacityD Schlosshan, D Barker, C Pepper, et al.Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|February 28, 2024
A prospective cohort study exploring the impact of tonsillectomy on feeding difficulties in childrenM E Walsh, R Retzler, J Huang, et al.Leukemia Research|November 27, 1999
Pleiotropic drug resistance in B-cell chronic lymphocytic leukaemia--the role of Bcl-2 family dysregulationC Pepper, A Thomas, J Hidalgo de Quintana, et al.Chirality|January 1, 1994
Racemisation of drug enantiomers by benzylic proton abstraction at physiological pHC Pepper, H J Smith, K J Barrell, et al.Molecular Oncology|March 11, 2015
Telomere fusion threshold identifies a poor prognostic subset of breast cancer patientsK Simpson, R E Jones, J W Grimstead, et al.Health Technology Assessment (Winchester, England)|November 5, 2010
Dronedarone for the treatment of atrial fibrillation and atrial flutterE Maund, C McKenna, M Sarowar, et al.British Journal of Cancer|June 21, 2007
Fludarabine-mediated suppression of the excision repair enzyme ERCC1 contributes to the cytotoxic synergy with the DNA minor groove crosslinking agent SJG-136 (NSC 694501) in chronic lymphocytic leukaemia cellsC Pepper, H Lowe, C Fegan, et al.Leukemia & Lymphoma|August 23, 2006
The SDF-1 G > A polymorphism at position 801 plays no role in multiple myeloma but may contribute to an inferior cause-specific survival in chronic lymphocytic leukemiaN C Pemberton, S Paneesha, L Hiller, et al.Pageof 5